https://www.huygensandversteegh.com/publications daily 0.75 2025-08-26 https://www.huygensandversteegh.com/publications/costutility-analysis-of-treatment-sequences-for-moderate-to-severe-crohns-disease monthly 0.5 2026-03-18 https://www.huygensandversteegh.com/publications/comparative-efficacy-of-all-available-pharmaceutical-therapies-for-moderate-to-severe-crohns-disease-a-systematic-review-and-network-meta-analysis monthly 0.5 2026-03-18 https://www.huygensandversteegh.com/publications/exit-strategies-in-patients-with-stable-ms-cost-effectiveness-of-extended-interval-dosing-of-ocrelizumab-and-natalizumab-versus-de-escalating-to-cladribine monthly 0.5 2025-07-28 https://www.huygensandversteegh.com/publications/treatment-related-toxicity-utility-and-patient-reported-outcomes-of-head-and-neck-cancer-patients-treated-with-proton-therapy-a-longitudinal-study monthly 0.5 2025-05-28 https://www.huygensandversteegh.com/publications/benefits-of-early-highly-effective-versus-escalation-treatment-strategies-in-relapsing-multiple-sclerosis-estimated-using-a-treatment-sequence-model monthly 0.5 2024-06-25 https://www.huygensandversteegh.com/publications/effectiveness-of-seizure-dogs-for-people-with-severe-refractory-epilepsy-results-from-the-episode-study monthly 0.5 2024-03-25 https://www.huygensandversteegh.com/publications/costeffectiveness-of-alternative-ntrk-testing-strategies-in-cancer-patients-followed-by-histology-independent-therapy-with-entrectinib-an-analysis-of-three-european-countries monthly 0.5 2023-10-30 https://www.huygensandversteegh.com/publications/a-hrefhttpswwwsciencedirectcomsciencearticlepiis2211034823006016benefits-of-sphingosine-1-phosphate-receptor-modulators-in-relapsing-ms-estimated-with-a-treatment-sequence-modela monthly 0.5 2023-10-30 https://www.huygensandversteegh.com/publications/hecopermed-personalized-medicine-from-a-health-economic-perspective-lessons-learned-and-potential-opportunities-ahead monthly 0.5 2023-10-03 https://www.huygensandversteegh.com/publications/budget-impact-and-transferability-of-costeffectiveness-of-dpyd-testing-in-metastatic-breast-cancer-in-three-health-systems monthly 0.5 2023-08-14 https://www.huygensandversteegh.com/publications/health-economic-benefits-of-anti-cd20-treatments-in-relapsing-multiple-sclerosis-estimated-using-a-treatment-sequence-model monthly 0.5 2023-10-03 https://www.huygensandversteegh.com/publications/societal-utilities-for-cognitive-impairment-in-schizophrenia-developing-a-preference-based-scoring-algorithm-based-on-the-schizophrenia-cognition-rating-scale monthly 0.5 2023-07-25 https://www.huygensandversteegh.com/publications/the-value-of-health-in-a-cost-effectiveness-analysis-theory-vs-practice monthly 0.5 2023-04-19 https://www.huygensandversteegh.com/publications/the-economics-of-patents-and-innovation-in-pharma monthly 0.5 2023-03-30 https://www.huygensandversteegh.com/publications/cost-effectiveness-analysis-of-treating-patients-with-ntrk-positive-cancer-with-the-histology-independent-therapy-entrectinib monthly 0.5 2022-10-11 https://www.huygensandversteegh.com/publications/future-medical-and-non-medical-costs-and-their-impact-on-the-cost-effectiveness-of-life-prolonging-interventions-a-comparison-of-five-european-countries monthly 0.5 2022-10-11 https://www.huygensandversteegh.com/publications/estimating-quality-of-life-decrements-in-oncology-using-time-to-death monthly 0.5 2022-07-07 https://www.huygensandversteegh.com/publications/correcting-for-discounting-and-loss-aversion-in-composite-time-trade-off monthly 0.5 2022-10-11 https://www.huygensandversteegh.com/publications/incremental-benefits-of-novel-pharmaceuticals-in-the-uk-a-cross-sectional-analysis-of-nice-technology-appraisals-from-2010-to-2020 monthly 0.5 2022-04-12 https://www.huygensandversteegh.com/publications/netbenefitpm monthly 0.5 2022-03-30 https://www.huygensandversteegh.com/publications/msmodelpaper monthly 0.5 2022-04-19 https://www.huygensandversteegh.com/publications/performance-of-the-eq-5d-5l-plus-respiratory-bolt-on-in-the-birmingham-chronic-obstructive-pulmonary-disease-cohort-study monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/the-potential-impact-of-digial-biomarkers-in-multiple-slerosis-in-the-netherlands-an-early-hta-technology-assessment-of-ms-sherpa monthly 0.5 2023-10-03 https://www.huygensandversteegh.com/publications/105p-prognostic-value-of-the-ntrk-fusion-biomarker-in-the-netherlands monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/modeling-the-cost-utility-of-treatment-sequences-for-multiple-sclerosis monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/distributional-consequences-of-including-survivor-costs-in-economic-evaluations-distributional-consequences-of-survivor-costs-in-economic-evaluations monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/hkuk9nmjw9j4yzsoi3249mh5ov3xpo monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/the-mental-health-quality-of-life-questionnaire-mhqol-development-and-first-psychometric-evaluation-of-a-new-measure-to-assess-quality-of-life-in-people-with-mental-health-problems monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/good-days-and-bad-days-measuring-health-related-quality-of-life-in-people-with-epilepsy monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/guidance-for-the-harmonisation-and-improvement-of-economic-evaluations-of-personalised-medicine monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/methodological-challenges-in-the-economic-evaluation-of-a-gene-therapy-for-rpe65-mediated-inherited-retinal-disease-the-value-of-vision monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/burden-of-providing-informal-care-for-patients-with-atrial-fibrillation monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/a-randomised-comparison-of-the-effect-of-haemodynamic-monitoring-with-cardiomems-in-addition-to-standard-care-on-quality-of-life-and-hospitalisations-in-patients-with-chronic-heart-failure monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/ravulizumab-for-paroxysmal-nocturnal-haemoglobinuria-a-single-technology-assessment monthly 0.5 2022-05-10 https://www.huygensandversteegh.com/publications/pharmaceutical-pricing-what-is-reasonable monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/evaluation-of-the-performance-of-algorithms-mapping-eortc-qlq-c30-onto-the-eq-5d-index-in-a-metastatic-colorectal-cancer-cost-effectiveness-model monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/early-cost-utility-analysis-of-tissue-engineered-heart-valves-compared-to-bioprostheses-in-the-aortic-position-in-elderly-patients monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/summarizing-patient-preferences-for-the-competitive-landscape-of-multiple-sclerosis-treatment-options monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/evaluating-the-effectiveness-and-cost-effectiveness-of-seizure-dogs-in-persons-with-medically-refractory-epilepsy-in-the-netherlands monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/protocol-comparing-the-effectiveness-and-cost-effectiveness-of-self-management-interventions-in-four-high-priority-chronic-conditions-in-europe-compar-eu-a-research-protocol monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/bioprosthetic-aortic-valve-replacement-in-elderly-patients-meta-analysis-and-microsimulation monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/severity-adjusted-probability-of-being-cost-effective monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/is-verlies-winst-stoppen-met-tnf-blokkers monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/can-time-heal-all-wounds-an-empirical-assessment-of-adaptation-to-functional-limitations-in-an-older-population monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/the-ross-procedure-a-systematic-review-meta-analysis-and-microsimulation monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/beyond-the-clinical-impact-of-aortic-and-pulmonary-valve-implantation-health-related-quality-of-life-informal-care-and-productivity monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/what-is-the-potential-of-tissue-engineered-pulmonary-valves-in-children monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/contemporary-outcomes-after-surgical-aortic-valve-replacement-with-bioprostheses-and-allografts-a-systematic-review-and-meta-analysis monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/a-cost-effectiveness-threshold-based-on-the-marginal-returns-of-cardiovascular-hospital-spending monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/when-is-it-too-expensive-cost-effectiveness-thresholds-and-health-care-decision-making monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/estimating-informal-caregiving-time-from-patient-eq-5d-data-the-informal-care-effect-icare-tool monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/how-much-does-a-heart-valve-implantation-cost-and-what-are-the-health-care-costs-afterwards monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/doelmatige-gezondheidszorg-hoe-besteden-we-onze-euros-het-beste monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/cost-effectiveness-of-the-angiotensin-receptor-neprilysin-inhibitor-sacubitrilvalsartan-for-patients-with-chronic-heart-failure-and-reduced-ejection-fraction-in-the-netherlands monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/the-risk-in-avoiding-risk-optimizing-decision-making-in-structural-heart-disease-interventions monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/health-related-quality-of-life-and-its-determinants-in-patients-with-metastatic-renal-cell-carcinoma monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/systematic-review-of-model-based-economic-evaluations-of-heart-valve-implantations monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/are-health-state-valuations-from-the-general-public-biased-a-test-of-health-state-reference-dependency-using-self-assessed-health-and-an-efficient-discrete-choice-experiment monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/conceptual-model-for-early-health-technology-assessment-of-current-and-novel-heart-valve-interventions monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/from-good-to-better-new-dutch-guidelines-for-economic-evaluations-in-healthcare monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/patient-and-general-public-preferences-for-health-states-a-call-to-reconsider-current-guidelines monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/impact-on-the-incremental-cost-effectiveness-ratio-of-using-alternatives-to-eq-5d-in-a-markov-model-for-multiple-sclerosis monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/dutch-tariff-for-the-five-level-version-of-eq-5d monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/exploring-the-variation-in-implementation-of-a-copd-disease-management-programme-and-its-impact-on-health-outcomes-a-post-hoc-analysis-of-the-recode-cluster-randomised-trial monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/cost-effectiveness-of-including-a-nurse-specialist-in-the-treatment-of-urinary-incontinence-in-primary-care-in-the-netherlands monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/testing-mapping-algorithms-of-the-cancer-specific-eortc-qlq-c30-onto-eq-5d-in-malignant-mesothelioma monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/which-factors-may-determine-the-necessary-and-feasible-type-of-effectiveness-evidence-a-mixed-methods-approach-to-develop-an-instrument-to-help-coverage-decision-makers monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/introducing-the-composite-time-trade-off-a-test-of-feasibility-and-face-validity monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/time-trade-off-one-methodology-different-methods monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/time-to-tweak-the-tto-results-from-a-comparison-of-alternative-specifications-of-the-tto monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/would-you-rather-be-ill-now-or-later monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/an-assessment-of-the-external-validity-of-mapping-qlq-c30-to-eq-5d-preferences monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/lead-time-tto-leading-to-better-health-state-valuations monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/condition-specific-preference-based-measures-benefit-or-burden monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/mapping-qlq-c30-haq-and-msis-29-on-eq-5d monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/mapping-onto-eq-5-d-for-patients-in-poor-health monthly 0.5 2022-03-16 https://www.huygensandversteegh.com/publications/category/epilepsy monthly 0.5 https://www.huygensandversteegh.com/publications/category/Health+Economics monthly 0.5 https://www.huygensandversteegh.com/publications/category/informal+care monthly 0.5 https://www.huygensandversteegh.com/publications/category/Brain+Sciences monthly 0.5 https://www.huygensandversteegh.com/publications/category/Frontiers+in+Neurology monthly 0.5 https://www.huygensandversteegh.com/publications/category/methods monthly 0.5 https://www.huygensandversteegh.com/publications/category/Tumour+agnostic+therapies monthly 0.5 https://www.huygensandversteegh.com/publications/category/Quality+of+Life+Research monthly 0.5 https://www.huygensandversteegh.com/publications/category/Circulation%3A+Cardiovascular+Quality+and+Outcomes monthly 0.5 https://www.huygensandversteegh.com/publications/category/Multiple+Sclerosis+Journal-ETC monthly 0.5 https://www.huygensandversteegh.com/publications/category/oncology monthly 0.5 https://www.huygensandversteegh.com/publications/category/NICE+STA monthly 0.5 https://www.huygensandversteegh.com/publications/category/artificial+intelligence monthly 0.5 https://www.huygensandversteegh.com/publications/category/rare+diseases monthly 0.5 https://www.huygensandversteegh.com/publications/category/trial+protocol monthly 0.5 https://www.huygensandversteegh.com/publications/category/Clinical+and+Translational+Radiation+Oncology monthly 0.5 https://www.huygensandversteegh.com/publications/category/Journal+of+Thoracic+Cardiovascular+Surgery monthly 0.5 https://www.huygensandversteegh.com/publications/category/The+Lancet%3A+Regional+Health+Europe monthly 0.5 https://www.huygensandversteegh.com/publications/category/Advances+in+Therapy monthly 0.5 https://www.huygensandversteegh.com/publications/category/Value+in+Health monthly 0.5 https://www.huygensandversteegh.com/publications/category/heart+failure monthly 0.5 https://www.huygensandversteegh.com/publications/category/Multiple+Sclerosis+Journal monthly 0.5 https://www.huygensandversteegh.com/publications/category/European+Journal+of+Cardiothoracic+Surgery monthly 0.5 https://www.huygensandversteegh.com/publications/category/PLoS+One monthly 0.5 https://www.huygensandversteegh.com/publications/category/chronic+diseases monthly 0.5 https://www.huygensandversteegh.com/publications/category/multiple+sclerosis monthly 0.5 https://www.huygensandversteegh.com/publications/category/Social+Science+%26+Medicine monthly 0.5 https://www.huygensandversteegh.com/publications/category/cardiac+disease monthly 0.5 https://www.huygensandversteegh.com/publications/category/European+Journal+of+Health+Economics monthly 0.5 https://www.huygensandversteegh.com/publications/category/Netherlands+Heart+Journal monthly 0.5 https://www.huygensandversteegh.com/publications/category/Personalized+Medicine monthly 0.5 https://www.huygensandversteegh.com/publications/category/Book+chapter monthly 0.5 https://www.huygensandversteegh.com/publications/category/Annals+of+Oncology monthly 0.5 https://www.huygensandversteegh.com/publications/category/Structural+Heart monthly 0.5 https://www.huygensandversteegh.com/publications/category/Medical+Decision+Making monthly 0.5 https://www.huygensandversteegh.com/publications/category/Neurology monthly 0.5 https://www.huygensandversteegh.com/publications/category/NTvG monthly 0.5 https://www.huygensandversteegh.com/publications/category/Health+%26+Quality+of+Life+Outcomes monthly 0.5 https://www.huygensandversteegh.com/publications/category/BMJ+Open monthly 0.5 https://www.huygensandversteegh.com/publications/category/Gastro+Hep+Advances monthly 0.5 https://www.huygensandversteegh.com/publications/category/personalised+medicine monthly 0.5 https://www.huygensandversteegh.com/publications/category/Pharmacoeconomics monthly 0.5 https://www.huygensandversteegh.com/publications/category/Annals+of+Thoracic+Surgery monthly 0.5 https://www.huygensandversteegh.com/publications/category/quality+of+life monthly 0.5 https://www.huygensandversteegh.com/publications/category/openHeart monthly 0.5 https://www.huygensandversteegh.com/publications/category/npj+Primary+Care+Respiratory+Medicine monthly 0.5 https://www.huygensandversteegh.com/publications/category/Multiple+Sclerosis+and+Related+Disorders monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Heart+failure monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Head+%26+Neck+cancer monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Crohn monthly 0.5 https://www.huygensandversteegh.com/publications/tag/chronic+diseases monthly 0.5 https://www.huygensandversteegh.com/publications/tag/multiple+sclerosis monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Artificial+Intelligence monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Epilepsy monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Informal+care monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Schizophrenia monthly 0.5 https://www.huygensandversteegh.com/publications/tag/cardiac+disease monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Oncology monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Arthritis monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Netherlands+Heart+Journal monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Cost-utility+analysis monthly 0.5 https://www.huygensandversteegh.com/publications/tag/NICE+STA monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Cost-utility monthly 0.5 https://www.huygensandversteegh.com/publications/tag/personalized+medicine monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Quality+of+life monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Trial+protocol monthly 0.5 https://www.huygensandversteegh.com/publications/tag/quality+of+life monthly 0.5 https://www.huygensandversteegh.com/publications/tag/Methods monthly 0.5 https://www.huygensandversteegh.com/home daily 1.0 2022-04-04 https://images.squarespace-cdn.com/content/v1/5ede5d5c4e1eb54d74680dd4/1592230716373-ZT0K3F4FT1OIRFNZ1MNL/Thrapy+copy+2.png Home https://images.squarespace-cdn.com/content/v1/5ede5d5c4e1eb54d74680dd4/1592230746331-7KHTZVVBPJJ1MBAAH1K3/Pills+copy+2.png Home https://images.squarespace-cdn.com/content/v1/5ede5d5c4e1eb54d74680dd4/1592230803772-L1ERE96JGOYEVC5MY5FY/Accupuncture+copy+2.png Home https://images.squarespace-cdn.com/content/v1/61e7da86b2c1fb1cc77d2ec4/1642693188045-DPXJWH86RLS77FJ1GUHR/Matthijs+ESHPM+wit.jpg Home https://images.squarespace-cdn.com/content/v1/61e7da86b2c1fb1cc77d2ec4/1647424571017-5IIQR7MQZW9ORYBKZMNR/Simone+wit+jpg.jpg Home https://images.squarespace-cdn.com/content/v1/61e7da86b2c1fb1cc77d2ec4/0314568a-83d8-4b89-8d1c-2bfe0c3ae587/Cirkels+v4.jpg Home - Trust in numbers. Numbers rarely reflect the complex societal sensitivities regarding healthcare but they do provide insights in the efficiency and equity of healthcare interventions. We generate results that people can trust by carefully building health economic models that reflect clinical reality and involve all stakeholders. https://www.huygensandversteegh.com/contact daily 0.75 2022-03-16